Skip to Content
Translational Research Program (TRP)
Last Updated: 09/28/16

Leukemia SPOREs

Despite the fact that major advances in diagnosis and treatment were achieved in the last 50 years, especially in childhood leukemia, this group of diseases remains a very serious medical problem. According to the Surveillance, Epidemiology and End Results (SEER) Program data, it is estimated that in 2016 there will be a total of 60,140 new cases of leukemia in the U.S. (3.6% of all new cancer cases) and that 24,400 people will die of this disease. In 2013 there were an estimated 333,975 people living with, or in remission from, leukemia in the U.S. Leukemia takes a particularly heavy toll on younger Americans as it causes one-third of all cancer deaths in children and adolescents younger than 15 years. Over the last 20 years the incidence of this cancer has held steady while the death rate has only decreased very slightly. The first round of SPORE applications in leukemia took place in 2002, with the subsequent award of the first Leukemia SPORE in 2003.

University of Texas/MD Anderson

Hagop M. Kantarjian, M.D. [Click Here]
Professor and Chair
Department of Leukemia
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 428
Houston, TX 77030
Phone: (713) 792-7025
Fax: (713) 794-4297

For more information on this specific SPORE’s institution, please visit:

Washington University

Daniel C. Link, M.D. [Click Here]
Dept of Medicine, Oncology Division
Washington University
613 Southwest Tower
Campus Box 8007
660 South Euclid Avenue
St. Louis, MO 63110
Phone: (314) 362-8771
Fax: (314) 362-9333